Log in

NGLFINE NGL Fine-Chem Ltd. NSE · India

NGL Fine-Chem (NGLFINE) news

NGL Fine-Chem Ltd. is a public biotech or pharmaceutical company listed on NSE under the ticker NGLFINE, recorded under India. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest NGL Fine-Chem news

We have not published a story on NGL Fine-Chem yet. When there is news, it will appear here.

Questions about NGL Fine-Chem

What is the ticker symbol of NGL Fine-Chem?

NGL Fine-Chem Ltd. trades under the ticker NGLFINE on NSE.

Where is NGL Fine-Chem listed?

NGL Fine-Chem Ltd. is listed on NSE. Our directory also records these other listings: BSE:NGLFINE.

Which country or territory is NGL Fine-Chem listed under?

Our directory records NGL Fine-Chem Ltd. under India.

What does NGL Fine-Chem do?

Our directory classifies NGL Fine-Chem Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of NGL Fine-Chem?

The ISIN recorded for NGL Fine-Chem Ltd. is INE887E01022.

Does aibio.space cover NGL Fine-Chem?

aibio.space lists NGL Fine-Chem Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to NGL Fine-Chem?

Companies in our directory listed in the same country and business area as NGL Fine-Chem: Kimia Biosciences, PFIZER LIMITED, Torrent Pharmaceuticals, AstraZeneca Pharma India, Hikal, Lasa Supergenerics.

Investor discussion: NGL Fine-Chem

Members talk about NGL Fine-Chem (NGLFINE). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NSE:NGLFINE on TradingView.

Listing details

NGL Fine-Chem Ltd. is a public biotech or pharmaceutical company listed on NSE under the ticker NGLFINE, recorded under India. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
NGL Fine-Chem Ltd.
Ticker
NGLFINE
Listing
NSE
Country or territory
India
Business scope
Pharmaceuticals: Major
ISIN
INE887E01022
Other listed symbols
BSE:NGLFINE
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.